来源：新浪证券-红岸工作室 2月25日，爱迪特涨9.03%，成交额6.80亿元，换手率12.81%，总市值80.78亿元。 异动分析 专精特新+3D打印+牙科医疗+医疗器械概念+人民币贬值受益 1、专精特新"小巨人"企业是全国中小企业评定工作中最高等级、最具权威的荣誉称号，是指专注于细 分市场、创新能力强、市场占有率高、掌握关键核心技术、质量效益优的排头兵企业，对于提升中小企 业自身的竞争力，以及提升产业链、供应链稳定性和竞争力具有重大意义。公司已入选工信部国家级专 精特新小巨人企业名单。 2、根据公司官网显示，公司生产的CPD-100 3D打印机可进行30纳米高精度打印。 3、爱迪特(秦皇岛)科技股份有限公司主营业务为口腔修复材料的研发、生产和销售；口腔数字化设备 的设计和销售。公司主要产品为口腔修复材料、口腔数字化设备、口腔正畸产品、口腔预防产品。 4、爱迪特(秦皇岛)科技股份有限公司主营业务为口腔修复材料的研发、生产和销售；口腔数字化设备 的设计和销售。公司主要产品为口腔修复材料、口腔数字化设备、口腔正畸产品、口腔预防产品。 5、根据2024年年报，公司海外营收占比为61.85%，受益于人民币贬值。 ( ...

2月24日，爱迪特涨9.39%，成交额6.12亿元，换手率12.21%，总市值74.08亿元。 来源：新浪证券-红岸工作室 异动分析 专精特新+3D打印+牙科医疗+医疗器械概念+人民币贬值受益 区间今日近3日近5日近10日近20日主力净流入-2412.25万-3992.23万161.16万611.87万2700.13万 1、专精特新"小巨人"企业是全国中小企业评定工作中最高等级、最具权威的荣誉称号，是指专注于细 分市场、创新能力强、市场占有率高、掌握关键核心技术、质量效益优的排头兵企业，对于提升中小企 业自身的竞争力，以及提升产业链、供应链稳定性和竞争力具有重大意义。公司已入选工信部国家级专 精特新小巨人企业名单。 2、根据公司官网显示，公司生产的CPD-100 3D打印机可进行30纳米高精度打印。 3、爱迪特(秦皇岛)科技股份有限公司主营业务为口腔修复材料的研发、生产和销售；口腔数字化设备 的设计和销售。公司主要产品为口腔修复材料、口腔数字化设备、口腔正畸产品、口腔预防产品。 4、爱迪特(秦皇岛)科技股份有限公司主营业务为口腔修复材料的研发、生产和销售；口腔数字化设备 的设计和销售。公司主要产品为口腔修复材 ...

Core Viewpoint - Aidi Tech (Qinhuangdao) Co., Ltd. has shown a significant increase in stock price and trading volume, indicating positive market sentiment and potential growth opportunities in the dental medical and medical device sectors [1][2]. Company Overview - Aidi Tech specializes in the research, production, and sales of dental restoration materials and digital dental equipment, with main products including dental restoration materials, digital dental devices, orthodontic products, and preventive dental products [2][8]. - The company has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which signifies its strong market position and innovation capabilities [2]. Financial Performance - For the period from January to September 2025, Aidi Tech achieved a revenue of 747 million yuan, representing a year-on-year growth of 16.44%, and a net profit attributable to shareholders of 142 million yuan, reflecting a growth of 27.40% [8]. - The company's overseas revenue accounted for 61.85% of total revenue, benefiting from the depreciation of the RMB [3]. Market Position and Trading Activity - The stock price of Aidi Tech increased by 4.63% on February 11, with a trading volume of 251 million yuan and a turnover rate of 6.40%, leading to a total market capitalization of 5.88 billion yuan [1]. - The stock has seen a net inflow of 26.89 million yuan from major investors, indicating a positive trend in investor interest [5][6]. Technical Analysis - The average trading cost of Aidi Tech's shares is 49.66 yuan, with the current stock price fluctuating between resistance at 58.50 yuan and support at 50.20 yuan, suggesting potential for short-term trading strategies [7].

Core Viewpoint - Aidi Tech (Qinhuangdao) Co., Ltd. has shown a positive market performance with a 2.23% increase in stock price, reaching a market capitalization of 5.62 billion yuan, driven by its focus on dental restoration materials and digital dental equipment [1][8]. Group 1: Company Overview - Aidi Tech specializes in the research, production, and sales of dental restoration materials, digital dental equipment, orthodontic products, and preventive dental products [2][8]. - The company has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, indicating its strong market position and innovation capabilities [2]. - As of September 30, the company had 9,851 shareholders, with an average of 7,310 circulating shares per person, reflecting a slight increase in shareholder numbers [8]. Group 2: Financial Performance - For the period from January to September 2025, Aidi Tech achieved a revenue of 747 million yuan, representing a year-on-year growth of 16.44%, while the net profit attributable to shareholders was 142 million yuan, up 27.40% year-on-year [8]. - The company's overseas revenue accounted for 61.85% of total revenue, benefiting from the depreciation of the Renminbi [3]. Group 3: Product and Technology - Aidi Tech's CPD-100 3D printer is capable of high-precision printing at 30 nanometers, showcasing the company's technological advancements in the dental equipment sector [4]. Group 4: Market Activity - The stock has seen a net inflow of 14.64 million yuan from major investors today, with a total trading volume of 145 million yuan and a turnover rate of 3.82% [1][5]. - The average trading cost of the stock is 49.35 yuan, with the current price approaching a support level of 50.80 yuan, indicating potential market movements [7].

Core Viewpoint - Aidi Tech (Qinhuangdao) Co., Ltd. is experiencing growth in its dental medical and medical device sectors, benefiting from the depreciation of the RMB and its status as a "specialized, refined, distinctive, and innovative" enterprise [2][3]. Company Overview - Aidi Tech specializes in the research, production, and sales of dental restoration materials and digital dental equipment, with main products including dental restoration materials, digital dental devices, orthodontic products, and preventive dental products [2][2]. - The company was established on March 15, 2007, and is located in Qinhuangdao, Hebei Province. It went public on June 26, 2024 [8]. - The revenue composition of Aidi Tech includes 73.74% from dental restoration materials, 19.80% from digital dental equipment, and 6.46% from other products and services [8]. Financial Performance - For the period from January to September 2025, Aidi Tech achieved a revenue of 747 million yuan, representing a year-on-year growth of 16.44%, and a net profit attributable to shareholders of 142 million yuan, with a year-on-year increase of 27.40% [8]. - The company has distributed a total of 49.48 million yuan in dividends since its A-share listing [9]. Market Position and Recognition - Aidi Tech has been recognized as a national-level "specialized, refined, distinctive, and innovative" small giant enterprise, which signifies its strong market position, innovation capabilities, and high market share [2]. - The company benefits from a significant overseas revenue share of 61.85%, aided by the depreciation of the RMB [3]. Technical Analysis - The average trading cost of Aidi Tech's shares is 48.94 yuan, with recent trends indicating a rapid outflow of shares. The current stock price is near a support level of 50.80 yuan, which is critical for potential rebounds [7].

Core Viewpoint - Aidi Te (Qinhuangdao) Technology Co., Ltd. is experiencing growth in its dental medical and medical device sectors, benefiting from the depreciation of the RMB and its status as a "specialized, refined, and innovative" enterprise [2][3]. Company Overview - Aidi Te specializes in the research, production, and sales of dental restoration materials and digital dental equipment, with main products including dental restoration materials, digital dental devices, orthodontic products, and preventive dental products [2]. - The company was established on March 15, 2007, and is located in Qinhuangdao, Hebei Province. It was listed on June 26, 2024 [8]. - The revenue composition of Aidi Te includes 73.74% from dental restoration materials, 19.80% from digital dental equipment, and 6.46% from other products and services [8]. Financial Performance - For the period from January to September 2025, Aidi Te achieved a revenue of 747 million yuan, representing a year-on-year growth of 16.44%, and a net profit attributable to shareholders of 142 million yuan, with a growth of 27.40% [8]. - The company has a total market capitalization of 5.456 billion yuan, with a trading volume of 120 million yuan and a turnover rate of 3.23% on February 2 [1]. Market Position and Recognition - Aidi Te has been recognized as a national-level "specialized, refined, and innovative" small giant enterprise, which signifies its strong innovation capabilities and high market share in niche markets [2]. - The company benefits from a significant overseas revenue share of 61.85%, which is positively impacted by the depreciation of the RMB [3]. Product Innovation - The company produces the CPD-100 3D printer, capable of achieving high-precision printing at 30 nanometers [4].

Core Points - The establishment of the postdoctoral research workstation by Zhejiang Zhengya Dental Co., Ltd. marks a significant achievement in the integration of industry, academia, and research, showcasing the company's organizational capabilities and professional level in high-level talent cultivation [1][3][4] - The company received the "Zhejiang Province Postdoctoral Workstation" plaque, indicating a breakthrough in building research platforms and cultivating talent independently [3] - The research project presented by postdoctoral researcher Zhang Sijia integrates the company's advantages in material research and clinical transformation, with guidance from university mentors [3][4] Summary by Sections Event Overview - The postdoctoral research workstation inauguration and project review meeting was successfully organized by the product R&D department, demonstrating the company's commitment to academic collaboration and technological innovation [1][3] Key Participants - The event was attended by various leaders and experts, including Chen Xuepeng from Zhejiang University, Zhu Xiujuan from Zhengya Dental, and other notable figures from academia and the healthcare sector [1][3] Research Project - The expert review panel, led by Chen Xuepeng, unanimously agreed on the project's significant research value and broad industrialization prospects after thorough questioning and discussion [3][4] Company Commitment - CEO Yao Junfeng expressed gratitude for government support and expert guidance, emphasizing the company's intention to increase R&D investment and promote deep integration of industry and academia [3][4] Recognition and Support - The South Lake District Human Resources and Social Security Bureau acknowledged Zhengya Dental's achievements in technological innovation and talent development, pledging continued support for the postdoctoral workstation [3][4]

Core Viewpoint - Aidi Te (Qinhuangdao) Technology Co., Ltd. has seen a stock price increase of 3.34% with a market capitalization of 4.847 billion yuan, benefiting from its focus on dental medical materials and 3D printing technology [1][2]. Company Overview - Aidi Te specializes in the research, production, and sales of dental restoration materials and digital dental equipment, with main products including dental restoration materials, digital dental devices, orthodontic products, and preventive dental products [2][4]. - The company has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, indicating its strong innovation capabilities and high market share in niche markets [3]. - As of June 30, 2025, Aidi Te's revenue composition includes 73.74% from dental restoration materials, 19.80% from digital dental equipment, and 6.46% from other products and services [8]. Financial Performance - For the first half of 2025, Aidi Te achieved a revenue of 486 million yuan, representing a year-on-year growth of 17.22%, and a net profit attributable to shareholders of 92.04 million yuan, up 19.86% year-on-year [8]. - The company's overseas revenue accounted for 61.85% of total revenue, benefiting from the depreciation of the Chinese yuan [4]. Market Activity - On October 9, the stock recorded a trading volume of 77.8274 million yuan with a turnover rate of 2.41%, indicating active market participation [1]. - The main capital inflow for the day was 3.862 million yuan, with a slight increase in main capital positions over the past two days [5][6]. Technical Analysis - The average trading cost of the stock is 47.91 yuan, with the current price approaching a support level of 44.05 yuan, suggesting potential volatility in the near term [7].

Core Viewpoint - UBS reported that Angelalign (06699) exceeded expectations in its interim performance, with a significant increase in revenue and net profit [1] Financial Performance - Revenue for the first half reached $161 million, representing a year-on-year growth of 33.1%, surpassing UBS's expectations [1] - Net profit amounted to $14.2 million, showing a remarkable year-on-year increase of 584%, aligning with expectations [1] - Adjusted net profit was $19.5 million, reflecting an 85% year-on-year growth [1] - Total case volume increased by 47.7% year-on-year, indicating strong operational performance [1] - Gross margin remained stable at 62.4% [1] Analyst Recommendations - UBS raised the target price from HKD 82 to HKD 91 [1] - The earnings per share forecast was changed from RMB to USD [1] - UBS reiterated a "Buy" rating for the stock [1]